UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.220

Sortiert nach

The Role of Continuing Medical Education in Increasing Enrollment in Prescription Drug Monitoring Programs

Clinical therapeutics, 2017-09, Vol.39 (9), p.1896-1902.e2

2017

Link zum Volltext

Verfügbarkeit prüfen

Meeting The Challenges: How Ema Communicates The Benefits and Risks Of Medicines to The Public

Clinical therapeutics, 2017-08, Vol.39 (8), p.e99-e99

2017

Link zum Volltext

Verfügbarkeit prüfen

Steps Towards Safe and Predictable Drug Treatment – Picks From Five Decades

Clinical therapeutics, 2017-08, Vol.39 (8), p.e99-e99

Neuvonen, P.J

2017

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to ‘Demographic and Clinical Characteristics of Type 2 Diabetes Mellitus Patients Initiating Dipeptidyl Peptidase-4 Inhibitors - A Retrospective Study of UK General Practice’ Clin Ther 2016;8:1825–1832.e15

Clinical therapeutics, 2017-03, Vol.39 (3), p.662-662.e15

2017

Link zum Volltext

Verfügbarkeit prüfen

Erratum to “Pitavastatin vs Pravastatin in Reduction of Remnant Lipoprotein Cholesterol in Patients with Dyslipidemias” Clin Ther . 2016;39:1250--1251

Clinical therapeutics, 2017

Roever, Leonardo, MHS

2017

Link zum Volltext

Verfügbarkeit prüfen

Editorial Board

Clinical therapeutics, 2019, Vol.41 (8), p.ii-iii

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical therapeutics, 2019, Vol.41 (8), p.iv-vi

2019

Link zum Volltext

Verfügbarkeit prüfen

How to Promote Clinical Research in Cee?

Clinical therapeutics, 2016-10, Vol.38 (10), p.e3-e3

Spaventi, R

2016

Link zum Volltext

Verfügbarkeit prüfen

The Role Of Cyp2d6, Cyp3a4/5, And Abcb1 Polymorphisms In Patients Using Long-Acting Injectable Risperidone

Clinical therapeutics, 2016-10, Vol.38 (10), p.e10-e11

2016

Link zum Volltext

Verfügbarkeit prüfen

New Formulations of Old Analgesics

Clinical therapeutics, 2016-02, Vol.38 (2), p.424-425

Hersh, Elliot V., DMD, MS, PhD

2016

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to ‘Outbreak Management’

Clinical therapeutics, 2016-02, Vol.38 (2), p.428-428

Jhaveri, Ravi, MD

2016

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to ‘Effects of Paroxetine, a CYP2D6 Inhibitor, on the Pharmacokinetic properties of Hydrocodone after Coadministration With a Single-entity, Once-daily, Extended-release Hydrocodone Tablet’

Clinical therapeutics, 2016, Vol.38 (1), p.232-232

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of CHA2 DS2 VASc Score on Candidacy for Anticoagulation in Patients With Atrial Fibrillation: A Multipayer Analysis

Clinical therapeutics, 2016

2016

Link zum Volltext

Verfügbarkeit prüfen

Comment Re: Kapil et al. 2015

Clinical therapeutics, 2016, Vol.38 (1), p.229-230

2016

Link zum Volltext

Verfügbarkeit prüfen

To the Editor

Clinical therapeutics, 2016

Walson, Philip D., MD

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical Therapeutics 38 (2016) 1451-63Corrigendum to Initial Experience With Tofacitinib in Clinical Practice: Treatment Patterns and Costs of Tofacitinib Administered as Monotherapy or in Combination With Conventional Synthetic DMARDs in 2 US Health Care Claims Databases

Clinical therapeutics, 2016

2016

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to ‘Inpatient Resource Utilization and Cost Burden of Deep Vein Thrombosis and Pulmonary Embolism in the United States’ Clin Ther 2015;37:62–70

Clinical therapeutics, 2015-10, Vol.37 (10), p.2382-2383

2015

Link zum Volltext

Verfügbarkeit prüfen

Potential Drug-Drug Interactions in Hospitals of West Kazakhstan

Clinical therapeutics, 2017-08, Vol.39 (8), p.e72-e72

2017

Link zum Volltext

Verfügbarkeit prüfen

A Tribute to a Pionner in Drug Utilization Reserch: Mu dr. Ludvík Štika

Clinical therapeutics, 2017-08, Vol.39 (8), p.e101-e102

Bergman, U

2017

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to ‘Pharmacokinetics and Pharmacodynamics of Ticagrelor and Prasugrel in Healthy Korean Male Volunteers’

Clinical therapeutics, 2015-09, Vol.37 (9), p.2149-2149

2015

Link zum Volltext

Verfügbarkeit prüfen

SGLT2 inhibitors

Clinical therapeutics, 2015-08, Vol.37 (8), p.e162-e162

Brito, M

2015

Link zum Volltext

Verfügbarkeit prüfen

Drug-Induced Nephrotoxicity: A Frequent Cause of Hospitalization In Nephrology

Clinical therapeutics, 2015-08, Vol.37 (8), p.e28-e28

2015

Link zum Volltext

Verfügbarkeit prüfen

Parameter estimation performance for sigmoid emax models in exposure-response Relationship

Clinical therapeutics, 2015-08, Vol.37 (8), p.e87-e87

2015

Link zum Volltext

Verfügbarkeit prüfen

Agomelatin for treatment of depressive disorders in Russia: a cost-utility analysis

Clinical therapeutics, 2015-08, Vol.37 (8), p.e102-e103

2015

Link zum Volltext

Verfügbarkeit prüfen

Detection of unnotified adverse drug reactions (adr). Active pharmacovigilance (apv)

Clinical therapeutics, 2015-08, Vol.37 (8), p.e133-e133

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 4.220

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe Lancet

ThemaEducation & Educational Research

Zeitschrift / SerieClinical Therapeutics

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.220)
Mit Volltextzugriff
(4.217)

Sprache

Englisch
(4.220)
Japanisch
(285)
Russisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta.com
(4.220)
Elsevier ScienceDirect Journals Complete
(4.220)
IngentaConnect Journals
(4.182)
MEDLINE
(2.342)
EZB Free E-Journals
(1)

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

The Role of Continuing Medical Education in Increasing Enrollment in Prescription Drug Monitoring Programs

Meeting The Challenges: How Ema Communicates The Benefits and Risks Of Medicines to The Public

Steps Towards Safe and Predictable Drug Treatment – Picks From Five Decades

Corrigendum to ‘Demographic and Clinical Characteristics of Type 2 Diabetes Mellitus Patients Initiating Dipeptidyl Peptidase-4 Inhibitors - A Retrospective Study of UK General Practice’ Clin Ther 2016;8:1825–1832.e15

Erratum to “Pitavastatin vs Pravastatin in Reduction of Remnant Lipoprotein Cholesterol in Patients with Dyslipidemias” Clin Ther . 2016;39:1250--1251

Editorial Board

Table of Contents

How to Promote Clinical Research in Cee?

The Role Of Cyp2d6, Cyp3a4/5, And Abcb1 Polymorphisms In Patients Using Long-Acting Injectable Risperidone

New Formulations of Old Analgesics

Corrigendum to ‘Outbreak Management’

Corrigendum to ‘Effects of Paroxetine, a CYP2D6 Inhibitor, on the Pharmacokinetic properties of Hydrocodone after Coadministration With a Single-entity, Once-daily, Extended-release Hydrocodone Tablet’

Impact of CHA2 DS2 VASc Score on Candidacy for Anticoagulation in Patients With Atrial Fibrillation: A Multipayer Analysis

Comment Re: Kapil et al. 2015

To the Editor

Clinical Therapeutics 38 (2016) 1451-63Corrigendum to Initial Experience With Tofacitinib in Clinical Practice: Treatment Patterns and Costs of Tofacitinib Administered as Monotherapy or in Combination With Conventional Synthetic DMARDs in 2 US Health Care Claims Databases

Corrigendum to ‘Inpatient Resource Utilization and Cost Burden of Deep Vein Thrombosis and Pulmonary Embolism in the United States’ Clin Ther 2015;37:62–70

Potential Drug-Drug Interactions in Hospitals of West Kazakhstan

A Tribute to a Pionner in Drug Utilization Reserch: Mu dr. Ludvík Štika

Corrigendum to ‘Pharmacokinetics and Pharmacodynamics of Ticagrelor and Prasugrel in Healthy Korean Male Volunteers’

SGLT2 inhibitors

Drug-Induced Nephrotoxicity: A Frequent Cause of Hospitalization In Nephrology

Parameter estimation performance for sigmoid emax models in exposure-response Relationship

Agomelatin for treatment of depressive disorders in Russia: a cost-utility analysis

Detection of unnotified adverse drug reactions (adr). Active pharmacovigilance (apv)

Aktive Filter

Suchergebnisse filtern